- Home
- SD vs CYRX Comparison
SD vs CYRX Comparison
Compare SD & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SD | CYRX |
|---|---|---|
| Founded | 2006 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 502.8M | 774.7M |
| IPO Year | 2006 | 2008 |
Fundamental Metrics
Financial Performance| Metric | SD | CYRX |
|---|---|---|
| Price | $13.16 | $15.18 |
| Analyst Decision | Strong Sell | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | ★ $15.00 | $13.31 |
| AVG Volume (30 Days) | 265.7K | ★ 701.4K |
| Earning Date | 05-05-2026 | 05-04-2026 |
| Dividend Yield | ★ 3.07% | N/A |
| EPS Growth | 12.43 | ★ 156.22 |
| EPS | ★ 0.50 | N/A |
| Revenue | N/A | ★ $176,177,000.00 |
| Revenue This Year | $12.65 | $11.06 |
| Revenue Next Year | $1.75 | $8.45 |
| P/E Ratio | $26.86 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.89 | $6.69 |
| 52 Week High | $18.45 | $16.89 |
Technical Indicators
Market Signals| Indicator | SD | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 37.64 | 46.17 |
| Support Level | N/A | $14.54 |
| Resistance Level | $13.99 | $16.76 |
| Average True Range (ATR) | 0.32 | 0.81 |
| MACD | 0.02 | -0.17 |
| Stochastic Oscillator | 0.41 | 26.87 |
Price Performance
Historical ComparisonAbout SD SandRidge Energy Inc.
SandRidge Energy Inc is a United States-based oil and natural gas company. It is engaged in the exploration, development, and production of crude oil, natural gas, and Natural gas liquids. Business activities of the group include Exploration and Production, Drilling and Oil Field Services, and Midstream Gas Services. The company's primary areas of operation are the Mid-Continent in Oklahoma and Kansas.
About CYRX CryoPort Inc.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.